Literature DB >> 6097223

Binding in vitro to rat liver receptors does not correlate with activities in vivo of bovine somatotropin. Use of chemically modified derivatives as probes.

L P Roguin, J M Delfino, N Vita, A C Paladini.   

Abstract

Bovine somatotropin with an increasing number of its carboxylate groups modified by reaction with glycine methyl ester in the presence of a water-soluble carbodi-imide was tested for its activity in different bioassays. Only those derivatives which were known to be active in the body-weight-increase bioassay were able to compete with 125I-labelled bovine somatotropin for their specific binding sites in vivo. No difference was found in the rate of clearance of a poorly active derivative as compared with that of native somatotropin. In contrast, both active and inactive derivatives were found to be equally effective in displacing the tracer from its binding sites present in isolated cells and membrane preparations from rat liver. These results suggest that the liver somatogenic receptors studied in vitro are less discriminating than those detected in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097223      PMCID: PMC1144462          DOI: 10.1042/bj2240535

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Methods for assessing immunologic and biologic properties of iodinated peptide hormones.

Authors:  J Roth
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  PURIFICATION OF BOVINE GROWTH HORMONE.

Authors:  J M DELLACHA; M SONENBERG
Journal:  J Biol Chem       Date:  1964-05       Impact factor: 5.157

3.  Binding of human growth hormone to rat liver membranes: lactogenic and somatotropic sties.

Authors:  M C Postel-Vinay
Journal:  FEBS Lett       Date:  1976-10-15       Impact factor: 4.124

4.  Growth hormone radiologand assay unresponsive to human prolactin.

Authors:  H Etzrodt; K A Musch; M Schleyer; E F Pfeiffer
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

5.  Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.

Authors:  B I Posner; P A Kelly; R P Shiu; H G Friesen
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

6.  Radioreceptor assay for growth hormone.

Authors:  T Tsushima; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

7.  Ovarian binding of intact and desialytated hcg in vivo and in vitro.

Authors:  T Tsuruhara; E V Van Hall; M L Dufau; K J Catt
Journal:  Endocrinology       Date:  1972-08       Impact factor: 4.736

8.  Biological properties of hCG after removal of terminal sialic acid and galactose residues.

Authors:  T Tsuruhara; M L Dufau; J Hickman; K J Catt
Journal:  Endocrinology       Date:  1972-07       Impact factor: 4.736

9.  Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes.

Authors:  M B Ranke; C A Stanley; A Tenore; D Rodbard; A M Bongiovanni; J S Parks
Journal:  Endocrinology       Date:  1976-10       Impact factor: 4.736

10.  Detection of immunologically active zones in equine growth hormone.

Authors:  E Poskus; M M Zakin; H N Fernámdez; A C Paladini
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.